Skip to main content

Beta testing. Real payments work with crypto only. Card payments (Stripe) are test-only for now.

Back to news
Aussie Rules
5 min read

Aflac Incorporated $AFL Stock Sold by HighTower Advisors LLC

HighTower Advisors LLC lessened its position in Aflac Incorporated (NYSE:AFL – Free Report) by 25.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC.
Aflac Incorporated $AFL Stock Sold by HighTower Advisors LLC

Posted by Grant Hamersma on Nov 19th, 2026

HighTower Advisors LLC lessened its position in Aflac Incorporated (NYSE:AFL – Free Report) by 25.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 655,709 shares of the financial services provider’s stock after selling 229,026 shares during the period. HighTower Advisors LLC’s holdings in Aflac were worth $73,295,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Groupe la Francaise bought a new stake in Aflac in the 1st quarter worth about $25,000. Archer Investment Corp purchased a new position in shares of Aflac during the second quarter valued at approximately $26,000. Edmond DE Rothschild Holding S.A. purchased a new position in shares of Aflac during the second quarter valued at approximately $27,000. Markowski Investments bought a new position in Aflac during the second quarter valued at approximately $29,000. Finally, Washington Trust Advisors Inc. bought a new position in Aflac during the second quarter valued at approximately $29,000. Institutional investors own 67.44% of the company’s stock.

AFL stock opened at $125.24 on Thursday. The business’s 50-day moving average price is $119.14 and its 200-day moving average price is $116.91. The stock has a market cap of $61.94 billion, a P/E ratio of 17.02, a PEG ratio of 1.78 and a beta of 0.55. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 0.30. Aflac Incorporated has a twelve month low of $105.76 and a twelve month high of $131.18.

Aflac (NYSE:AFL – Get Free Report) last announced its quarterly earnings data on Wednesday, November 4th. The financial services provider reported $2.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.80 by $0.63. The firm had revenue of $4.30 billion during the quarter, compared to analysts’ expectations of $4.12 billion. Aflac had a net margin of 21.24% and a return on equity of 12.82%. The company’s revenue for the quarter was down 31.0% compared to the same quarter last year. During the same period in the prior year, the company posted $2.49 earnings per share. On average, equities research analysts forecast that Aflac Incorporated will post 7.37 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 1st. Shareholders of record on Wednesday, February 17th will be issued a dividend of $0.64 per share. This is a boost from Aflac’s previous quarterly dividend of $0.61. This represents a $2.56 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date of this dividend is Wednesday, February 17th. Aflac’s payout ratio is 35.57%.

AFL has been the topic of several research reports. Wolfe Research began coverage on shares of Aflac in a report on Wednesday, August 19th. They issued an “underperform” rating and a $103.00 target price on the stock. Keefe, Bruyette & Woods decreased their target price on shares of Aflac from $125.00 to $120.00 and set a “market perform” rating for the company in a research note on Friday, October 9th. Jefferies Financial Group raised their price target on Aflac from $108.00 to $112.00 and gave the stock a “hold” rating in a research note on Monday, August 10th. Barclays reissued an “underweight” rating and issued a $101.00 target price (up from $99.00) on shares of Aflac in a report on Wednesday, October 7th. Finally, UBS Group reissued a “neutral” rating and issued a $125.00 target price (up from $124.00) on shares of Aflac in a research report on Tuesday, October 6th. Four research analysts have rated the stock with a Buy rating, eight have given a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $118.73.

Get Our Latest Analysis on AFL

In other news, Director Joseph Moskowitz sold 600 shares of the company’s stock in a transaction dated Monday, November 9th. The stock was sold at an average price of $124.99, for a total value of $74,994.00. Following the completion of the transaction, the director owned 32,119 shares of the company’s stock, valued at $4,014,553.81. This represents a 1.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Post Holdings Co. Ltd. Japan sold 19,530 shares of the company’s stock in a transaction that occurred on Monday, November 16th. The stock was sold at an average price of $127.95, for a total value of $2,498,863.50. Following the completion of the transaction, the insider owned 50,058,899 shares of the company’s stock, valued at $6,405,036,127.05. The trade was a 0.04% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 695,092 shares of company stock worth $81,555,154. Insiders own 0.80% of the company’s stock.

Aflac Incorporated is an insurance company that provides supplemental health and life insurance to individuals and businesses. Its products are designed to help customers manage expenses that may not be covered by major medical insurance, including costs associated with accidents, cancer, critical illness and hospital stays. The company operates primarily in the United States and Japan. In the U.S., Aflac offers workplace benefits such as accident, disability, dental, vision and life insurance. In Japan, it provides products including cancer, medical and life insurance.

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.

1,341 Marathon Petroleum Corporation $MPC Shares Bought by HighTower Advisors LLC

1,148,513 Shares in Vanguard Short Duration Tax-Exempt Bond ETF $VSDM Bought by HighTower Advisors LLC

Comments0

Your sport, all in one place

Aussie Rules

Follow the stories, and hear of new ones in your feed and notifications.

Picks to explore

All Aussie Rules picks

About this story

About this story and its source

Who published the story, when it came out, and where to read more.

How the news feed works

It was published on November 19, 2026 and last updated on November 20, 2026. The time of the story is shown in your own time zone on the page.

Open the Aussie Rules news for more stories, or see the matches with analyst picks and the list of analysts to compare their records before you buy a pick.

Share your picks. Get paid for them.

Become an analyst on ForBets: publish your picks, sell them, and let readers see your record.